Molly Cole is a Biotech Venture Capital at Curie.Bio, whose known portfolio counts 9 companies.
Is Molly Cole a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechDrug DiscoveryFitnessGeneticsMedTechPharmaSpinout BuilderTherapeuticsWellness
Contacts
Affiliated funds' portfolios
Biotech Venture Capital at Curie.Bio, whose known portfolio counts 9 companies
- R1 Therapeutics
- Tesseract Medical Research
- Alkira Bio
- Cell Control Biotherapeutics
- Decrypt Biomedicine
- FunctionRx
- Osteologic Therapeutics
- Remunix
- Rhino Therapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Drug Discovery, Fitness and Genetics. Startups operating in these areas may find Molly Cole relevant.
Curie.Bio appears in Seed and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Molly Cole matches their raise.
Colleagues at Curie.Bio
Christoph Lengauer
CSO & co-founder
Boston, United States
Andrew Warren
Senior Director
Boston, United States
Devin Quinlan
Investment Principal
Cambridge, United States
Anthony Wiemelt
Head of Investment Diligence and Operations
Philadelphia, United States
Alexis Borisy
Investor
Boston, United States
Madison Goldstein
Investor
Brooklyn, United States
Zach Weinberg
Founder
United States
Ben Auspitz
Biotech Founder, Operator, and Investor
Cambridge, United States
Patrick Lee
Vice President
San Francisco, United States
Lazar Bojic
Investor
New York, United States
Michael Schlabach
Investor
Cambridge, United States
George Voren
Investor
Fort Lauderdale, United States
Pallavur Sivakumar
Vice President
Marietta, United States
Frequently asked questions
Who is Molly Cole?
Molly Cole is a venture capital investor based in New York, United States, listed as Biotech Venture Capital at Curie.Bio. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Molly Cole personally.
What does Molly Cole invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Fitness and Genetics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Molly Cole invest at?
Curie.Bio appears in Seed and Series A rounds across its known deals, and Molly Cole is listed there as Biotech Venture Capital. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Molly Cole listed at?
Molly Cole is listed as Biotech Venture Capital at Curie.Bio. 13 other people in the database share a firm with Molly Cole.
How do I contact Molly Cole?
An email address and a LinkedIn page are on file for Molly Cole. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal